CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5785.12M
Enterprise Value 3701.35M
Trailing P/E N/A
Forward P/E 1-6.59
PEG Ratio (5 yr expected) 1-0.42
Price/Sales (ttm)22.04
Price/Book (mrq)N/A
Enterprise Value/Revenue 319.69
Enterprise Value/EBITDA 6-7.78

Trading Information

Stock Price History

Beta (3Y Monthly) 1.44
52-Week Change 389.58%
S&P500 52-Week Change 32.31%
52 Week High 314.42
52 Week Low 35.75
50-Day Moving Average 312.27
200-Day Moving Average 39.74

Share Statistics

Avg Vol (3 month) 3455.14k
Avg Vol (10 day) 3406.38k
Shares Outstanding 557.72M
Float 46.43M
% Held by Insiders 17.32%
% Held by Institutions 175.19%
Shares Short (Jul 31, 2019) 43.66M
Short Ratio (Jul 31, 2019) 48.9
Short % of Float (Jul 31, 2019) 48.06%
Short % of Shares Outstanding (Jul 31, 2019) 46.34%
Shares Short (prior month Jun 28, 2019) 43.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jun 25, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-254.38%

Management Effectiveness

Return on Assets (ttm)-25.42%
Return on Equity (ttm)-312.96%

Income Statement

Revenue (ttm)35.62M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)14.80%
Gross Profit (ttm)-57.63M
EBITDA -90.09M
Net Income Avi to Common (ttm)-109.96M
Diluted EPS (ttm)-1.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)172.87M
Total Cash Per Share (mrq)2.95
Total Debt (mrq)53.3M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.42
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-96.15M
Levered Free Cash Flow (ttm)-69.85M